These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30879649)

  • 21. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522.
    Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C
    J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity.
    Khademi F; Derakhshan M; Yousefi-Avarvand A; Najafi A; Tafaghodi M
    Microb Pathog; 2018 Dec; 125():507-513. PubMed ID: 30352265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
    Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V
    J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
    Slütter B; Jiskoot W
    J Control Release; 2010 Nov; 148(1):117-121. PubMed ID: 20600405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curdlan oligosaccharides having higher immunostimulatory activity than curdlan in mice treated with cyclophosphamide.
    Tang J; Zhen H; Wang N; Yan Q; Jing H; Jiang Z
    Carbohydr Polym; 2019 Mar; 207():131-142. PubMed ID: 30599993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.
    Lin Y; Sun B; Jin Z; Zhao K
    ACS Appl Mater Interfaces; 2022 Nov; 14(47):52691-52701. PubMed ID: 36382954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
    Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
    Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucan Particles Are a Powerful Adjuvant for the HBsAg, Favoring Antiviral Immunity.
    Soares E; Groothuismink ZMA; Boonstra A; Borges O
    Mol Pharm; 2019 May; 16(5):1971-1981. PubMed ID: 30964694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabrication of chitosan-based emulsion as an adjuvant to enhance nasal mucosal immune responses.
    Li D; Li W; Li S; Zhang Y; Hu X; Liu S; Li Y
    Int J Biol Macromol; 2024 Jun; 272(Pt 2):132913. PubMed ID: 38851606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally.
    Mangal S; Pawar D; Garg NK; Jain AK; Vyas SP; Rao DS; Jaganathan KS
    Vaccine; 2011 Jul; 29(31):4953-62. PubMed ID: 21575664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.
    Dabaghian M; Latifi AM; Tebianian M; NajmiNejad H; Ebrahimi SM
    Vaccine; 2018 May; 36(20):2886-2895. PubMed ID: 29627234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan-based Nanoparticles in Mucosal Vaccine Delivery.
    Mehrabi M; Montazeri H; Mohamadpour Dounighi N; Rashti A; Vakili-Ghartavol R
    Arch Razi Inst; 2018 Sep; 73(3):165-176. PubMed ID: 30280836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles.
    Lebre F; Pedroso de Lima MC; Lavelle EC; Borges O
    Int J Pharm; 2018 Dec; 552(1-2):7-15. PubMed ID: 30244149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
    Moon HJ; Lee JS; Talactac MR; Chowdhury MY; Kim JH; Park ME; Choi YK; Sung MH; Kim CJ
    Vet Microbiol; 2012 Dec; 160(3-4):277-89. PubMed ID: 22763171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A fucoidan-quaternary chitosan nanoparticle adjuvant for anthrax vaccine as an alternative to CpG oligodeoxynucleotides.
    Chuang CC; Tsai MH; Yen HJ; Shyu HF; Cheng KM; Chen XA; Chen CC; Young JJ; Kau JH
    Carbohydr Polym; 2020 Feb; 229():115403. PubMed ID: 31826481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant synergy: the effects of nasal coadministration of adjuvants.
    Moschos SA; Bramwell VW; Somavarapu S; Alpar HO
    Immunol Cell Biol; 2004 Dec; 82(6):628-37. PubMed ID: 15550121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunostimulatory effect of N-2-hydroxypropyltrimethyl ammonium chloride chitosan-sulfate chitosan complex nanoparticles on dendritic cells.
    Xu C; Xing R; Liu S; Qin Y; Li K; Yu H; Li P
    Carbohydr Polym; 2021 Jan; 251():117098. PubMed ID: 33142636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan Nanoparticles Loaded with Truncated ORF2 Protein as an Oral Vaccine Candidate against Hepatitis E.
    Wei W; Behloul N; Wang W; Baha S; Liu Z; Shi R; Meng J
    Macromol Biosci; 2021 Apr; 21(4):e2000375. PubMed ID: 33624916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.